検索結果 521 件
JaLCDOI | 10.18926/AMO/60796 |
---|---|
フルテキストURL | 74_5_371.pdf |
著者 | Makimoto, Go| Ohashi, Kadoaki| Maeda, Yoshinobu| Kiura, Katsuyuki| |
抄録 | The prognosis of advanced non-small cell lung cancer (NSCLC) patients has improved in recent decades, especially for patients with an oncogenic driver mutation. Anaplastic lymphoma kinase (ALK) tyrosine kinase inhibitors (TKIs) are effective for patients with the echinoderm microtubule-associated protein-like 4-ALK fusion gene. Several ALK-TKIs have been established: the first-generation ALK-TKI, crizotinib; second-generation ALK-TKIs, alectinib and ceritinib; and third-generation ALK-TKI, lorlatinib. Some ALK-TKIs are effective for tumors that are resistant to other ALK-TKIs; however, as is known in epidermal growth factor receptormutant lung cancer, tumor resistance is inevitable. ALK-positive NSCLCs acquire resistance via various mechanisms, making it a heterogeneous disease. Therefore, it is necessary to develop next-generation treatment strategies, such as the use of next-generation ALK-TKIs for secondary mutations, or combination therapies with ALK-TKIs and other TKIs. In this review, we summarize the development and use of ALK-TKIs, prior pivotal clinical trials, and resistance mechanisms. |
キーワード | lung cancer anaplastic lymphoma kinase tyrosine kinase inhibitors resistance mechanism |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-10 |
巻 | 74巻 |
号 | 5号 |
出版者 | Okayama University Medical School |
開始ページ | 371 |
終了ページ | 379 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 33106692 |
Web of Science KeyUT | 000581970100001 |
NAID | 120006892922 |
JaLCDOI | 10.18926/AMO/60376 |
---|---|
フルテキストURL | 74_4_365.pdf |
著者 | Chuma, Masayuki| Kondo, Masateru| Zamami, Yoshito| Takechi, Kenshi| Goda, Mitsuhiro| Okada, Naoto| Shibata, Akitomo| Asada, Mizuho| Oto, Jun| Yanagawa, Hiroaki| Ishizawa, Keisuke| |
抄録 | Cystatin C-guided vancomycin (VCM) dosing is useful in critically ill patients. Its usefulness in septic patients with bacterial meningitis remains unknown, as there are no published reports. In this study, we sought to clarify its benefit. Cystatin C was used to guide VCM dosing in a septic bacterial meningitis patient with normal kidney function, according to therapeutic drug monitoring (TDM). Using cystatin C, the Bayesian method-based TDM made optimal VCM dosing possible, and decreased the predicted error (4.85 mg/L) compared to serum creatinine (16.83 mg/L). We concluded TDM of VCM using cystatin C can be considered in sepsis patients with bacterial meningitis with normal kidney function. |
キーワード | vancomycin, therapeutic drug monitoring cystatin C bacterial meningitis sepsis |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-08 |
巻 | 74巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 365 |
終了ページ | 370 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32843769 |
Web of Science KeyUT | 000562508700013 |
NAID | 120006880215 |
JaLCDOI | 10.18926/AMO/60372 |
---|---|
フルテキストURL | 74_4_335.pdf |
著者 | Yamamoto, Yumiko| Hayashi, Yoshihiro| Murakami, Ichiro| |
抄録 | Since the discovery of the NAB2-STAT6 gene fusion in 2013, solitary fibrous tumor (SFT) and hemangiopericytoma (HPC) have been considered the same disease. STAT6 nuclear stain is approved as a highly sensitive and specific marker to diagnose SFT/HPC from other tumors with similar histology. As the next step, detection of fusion variants that may predict clinical malignancy of SFT/HPC has been attempted. However, no fusion variants with a clear relation to malignancy have been identified. In this study, the clinical and histological backgrounds of 23 Japanese patients diagnosed with SFT/HPC from 2000 to 2019 at Kochi University Hospital were examined to identify factors potentially related to recurrence. A significant relationship to recurrence was detected for mitosis ≥ 1/10 HPF (400×), necrosis, and Ki-67>5%. These findings indicate that a deliberate investigation of histological features such as mitosis and necrosis is crucial for the clinical observation of SFT/ HPC patients. In addition, Ki-67 was revealed to be a useful parameter to predict recurrence in SFT/HPC patients. |
キーワード | solitary fibrous tumor hemangiopericytoma Ki-67 NAB2-STAT6 WHO classification WHO grading criteria Marseille Grading System |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-08 |
巻 | 74巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 335 |
終了ページ | 343 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32843765 |
Web of Science KeyUT | 000562508700009 |
NAID | 120006880211 |
JaLCDOI | 10.18926/AMO/60365 |
---|---|
フルテキストURL | 74_4_285.pdf |
著者 | Tsukahara, Kohei| Naitou, Hiromichi| Yorifuji, Takashi| Nosaka, Nobuyuki| Yamamoto, Hirotsugu| Osako, Takaaki| Nakao, Atsunori| the JaRPAC Study Group| |
抄録 | The importance of centralizing treatment services for severely ill children has been well established, but such entralization remains difficult in Japan. We aimed to compare the trauma and illness severity and mortality of children admitted to two common types of ICUs for children. According to the type of management and disposition of the medical provider, we classified ICUs as pediatric ICUs [PICUs] or general ICUs, and analyzed differences in endogenous and exogenous illness settings between them. Overall, 1,333 pediatric patients were included, with 1,143 patients admitted to PICUs and 190 patients to general ICUs. The Pediatric Cerebral Performance Category score (PCPC) at discharge was significantly lower in the PICU group (adjusted OR: 0.45; 95%CI: 0.23-0.88). Death and unfavorable neurological outcomes occurred less often in the PICU group (adjusted OR: 0.29; 95%CI: 0.14-0.60). However, when limited to exogenous illness, PCPC scores (adjusted OR: 0.38; 95%CI: 0.07-1.99) or death/unfavorable outcomes (adjusted OR: 0.72; 95%CI: 0.08-6.34) did not differ between the groups. PCPC deterioration and overall sequelae/death rates were lower in PICUs for children with endogenous illnesses, although the outcomes of exogenous illness were similar between the 2 unit types. Further studies on the necessity of centralization are warranted. |
キーワード | kids critical care mortality morbidity centralization |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-08 |
巻 | 74巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 285 |
終了ページ | 291 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32843759 |
Web of Science KeyUT | 000562508700003 |
NAID | 120006880204 |
JaLCDOI | 10.18926/AMO/60364 |
---|---|
フルテキストURL | 74_4_275.pdf |
著者 | Muro, Taiko| Nakamura, Shinichiro| Takaki, Akinobu| Onishi, Hideki| Wada, Nozomu| Yasunaka, Tetsuya| Uchida, Daisuke| Oyama, Atsushi| Adachi, Takuya| Shiraha, Hidenori| Okada, Hiroyuki| |
抄録 | Radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC) is a promising method for controlling tumors, although it does not entirely eliminate recurrence. Oxidative stress is associated with the progression of hepatocarcinogenesis, while also acting as an anticancer response. The objective of the present study was to investigate the factors influencing post-RFA outcomes. We recruited 235 newly diagnosed HCC patients who received RFA for single tumors. The patients with recurrence were sub-grouped into early and segmental recurrence groups. The characteristics of the sub-grouped patients were evaluated, including by measuring oxidative stress marker reactive oxygen metabolites and antioxidant marker OXY-adsorbent tests. The factors associated with poor survival were a high Child-Pugh score and early recurrence within 2 years in the same segment. The patients who experienced recurrence within 2 years in the same segment showed a larger tumor diameter than did others. According to a multivariate analysis, the OXY values were also significantly low in these patients. In conclusion, maintaining the antioxidant reservoir function with a high OXY value might be necessary to prevent early recurrence within the RFA-treated segment. |
キーワード | oxidative stress hepatocellular carcinoma recurrence, radiofrequency ablation |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-08 |
巻 | 74巻 |
号 | 4号 |
出版者 | Okayama University Medical School |
開始ページ | 275 |
終了ページ | 283 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32843758 |
Web of Science KeyUT | 000562508700002 |
NAID | 120006880203 |
JaLCDOI | 10.18926/AMO/59961 |
---|---|
フルテキストURL | 74_3_261.pdf |
著者 | Nakahara, Keiichi| Ikeda, Tokunori| Takamatsu, Koutaro| Tawara, Nozomu| Hara, Kentaro| Enokida, Yuki| Tanoue, Naomi| Narita, Sawana| Fujii, Akiko| Yamanouchi, Yoshinori| Morinaga, Jun| Yamashita, Satoshi| |
抄録 | Muscle biopsy can be used to confirm the diagnosis of neuromuscular diseases. However, it is unclear whether antibiotic prophylaxis prior to muscle biopsy is needed to prevent surgical site infection (SSI). We are conducting a phase 2, single-center, open-labeled, prospective randomized trial to clarify the need for antibiotic prophylaxis in patients at low risk for SSI undergoing muscle biopsy. Patients will be randomized to an antibiotic prophylaxis group or a control group, and the incidence of SSI will be compared between the groups. Our findings will clarify the need for antibiotic prophylaxis in this patient population. |
キーワード | muscle biopsy antibiotic prophylaxis |
Amo Type | Clinical Study Protocol |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 261 |
終了ページ | 264 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577026 |
Web of Science KeyUT | 000543363400011 |
NAID | 120006862802 |
JaLCDOI | 10.18926/AMO/59957 |
---|---|
フルテキストURL | 74_3_237.pdf |
著者 | Oyama, Atsushi| Uchida, Daisuke| Shiraha, Hidenori| Sawahara, Hiroaki| Kato, Ryo| Iwamuro, Masaya| Horiguchi, Shigeru| Okada, Hiroyuki| |
抄録 | The physiological role of the reduced expression of immortalized cells (REIC)/Dickkopf-3 (Dkk-3) protein in patients with hepatocellular carcinoma (HCC) remains unclear. In this study, we evaluated the effect of the REIC/Dkk-3 protein on HCC cell proliferation and assessed the relationship between the serum REIC/Dkk-3 protein level and the prognosis in patients with HCC. We evaluated the REIC/Dkk-3 protein-induced anticancer effects on Huh7 and Hep3B cells (HCC cell lines) in the presence of peripheral blood mononuclear cells (PBMCs), and found that combination treatment with REIC/Dkk-3 protein and PBMCs reduced the proliferation of HCC cells (Hep3B: 82.0%±16.3%; Huh7: 72.6%±9.1%). We also studied 194 HCC patients who underwent primary liver resection or primary radiofrequency ablation from 2008 to 2017. Serum REIC/Dkk-3 protein levels were measured by an enzyme-linked immunosorbent assay and compared to the prognostic data. The 3-year disease-free survival of the REIC/Dkk-3 high group was significantly higher than that in the REIC/Dkk-3 low group. In conclusion, this is the first study investigating the relationship between HCC patient survival and serum REIC/Dkk-3 protein levels in a large population. Based on the results, the serum REIC/Dkk-3 protein level should be considered a new prognostic marker for patients with HCC. |
キーワード | enzyme-linked immunosorbent assay liver resection primary radiofrequency ablation Huh7 Hep3B |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 237 |
終了ページ | 243 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577022 |
Web of Science KeyUT | 000543363400007 |
NAID | 120006862798 |
JaLCDOI | 10.18926/AMO/59954 |
---|---|
フルテキストURL | 74_3_221.pdf |
著者 | Yagura, Takuma| Oe, Kenichi| Paku, Masaaki| Tajima, Takeshi| Nakamura, Masaya| Iida, Hirokazu| Saito, Takanori| |
抄録 | We retrospectively evaluated the cases of 169 hip fracture patients, their previous fractures, and the contralateral hip joint’s morphology. A history of contralateral hip fracture was present in 23 patients (Contra group). The other patients had a unilateral hip fracture: a trochanteric fracture (Troch group, n=73) or a femoral neck fracture (Neck group, n=73). In the Troch and Neck groups, we used anteroposterior and cross-table axialview radiographs of the contralateral hip to evaluate the proximal femur’s anatomy. In the Contra group, the concordance rate between the first and second types of hip fracture was 65.2%, and the second hip fracture’s morphology indicated that the trochanteric fracture had a cam deformity in terms of the femoral head-neck ratio. The average alpha angle and femoral head-neck offset in the Troch group were significantly larger than those in the Neck group. In the Neck group, pistol-grip deformities of Arbeitsgemeinschaft für Osteosynthesefragen types B1 (subcapital), B2 (transcervical), and B3 (displaced) were observed in 42.1%, 75%, and 6% of cases, respectively. There was a smaller alpha angle and a larger femoral head-neck offset in the contralateral hip of femoral neck fractures; thus, the “cam deformity” may protect against femoral neck fractures. |
キーワード | cam deformity femoral neck fracture trochanteric fracture bilateral hip fractures |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 221 |
終了ページ | 227 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577020 |
Web of Science KeyUT | 000543363400006 |
NAID | 120006862796 |
JaLCDOI | 10.18926/AMO/59949 |
---|---|
フルテキストURL | 74_3_191.pdf |
著者 | Ohashi, Keiji| Sada, Ken-Ei| Asano, Yosuke| Hayashi, Keigo| Yamamura, Yuriko| Asano, Sumie Hiramatsu| Miyawaki, Yoshia| Morishita, Michiko| Katsuyama, Eri| Watanabe, Haruki| Tatebe, Noriko| Narazaki, Mariko| Matsumoto, Yoshinori| Sunahori-Watanabe, Katsue| Kawabata, Tomoko| Yajima, Nobuyuki| Wada, Jun| |
抄録 | Chronic damage accumulation affects not only mortality but also quality of life in patients with systemic lupus erythematosus (SLE). Risk factors for chronic damage were explored in SLE through different onset eras. Two hundred forty-five patients at Okayama University Hospital and Showa University Hospital were divided into three groups based on the onset era: a past-onset group (onset before 1995; n=83), middle-onset group (1996-2009; n=88), and recent-onset group (after 2010; n=74). The mean Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) score as an index of chronic damage was 1.93, 1.24, and 0.53 in the past-, middle-, and recent-onset groups, respectively. In the pastonset group, the total SDI score was significantly associated with glucocorticoid monotherapy by linear regression analysis (β-coefficient [β]=0.63; 95% confidence interval [CI], 0.21-1.05) and C-reactive protein levels (β=0.67; 95% CI, 0.27-1.07). In the middle-onset group, the total SDI score was significantly associated with the SLE Disease Activity Index at registration (β=0.09; 95% CI, 0.03-0.12). Reducing the accumulation of chronic damage in SLE patients might be possible with the concomitant use of immunosuppressants and tight control of disease activity. |
キーワード | systemic lupus erythematosus chronic damage glucocorticoids, disease activity disease duration |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-06 |
巻 | 74巻 |
号 | 3号 |
出版者 | Okayama University Medical School |
開始ページ | 191 |
終了ページ | 198 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32577016 |
Web of Science KeyUT | 000543363400002 |
NAID | 120006862791 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Obata, Kyoichi| Okui, Tatsuo| Kishimoto, Koji| Ibaragi, Soichiro| Sasaki, Akira| |
発行日 | 2020-04-28 |
出版物タイトル | Case Reports in Medicine |
巻 | 2020巻 |
出版者 | Hindawi |
開始ページ | 4814519 |
ISSN | 1687-9627 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2020 Kyoichi Obata et al. |
論文のバージョン | publisher |
PubMed ID | 32411253 |
DOI | 10.1155/2020/4814519 |
Web of Science KeyUT | 000534278000001 |
関連URL | isVersionOf https://doi.org/10.1155/2020/4814519 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Wang, Dengli| Liu, Keyue| Fukuyasu, Yusuke| Teshigawara, Kiyoshi| Fu, Li| Wake, Hidenori| Ohtsuka, Aiji| Nishibori, Masahiro| |
キーワード | middle cerebral artery occlusion high-mobility group box 1 subcellular localization and subcellular organelle |
発行日 | 2020-03-06 |
出版物タイトル | Cells |
巻 | 9巻 |
号 | 3号 |
出版者 | MDPI |
開始ページ | 643 |
ISSN | 2073-4409 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © 2020 by the authors. |
論文のバージョン | publisher |
PubMed ID | 32155899 |
DOI | 10.3390/cells9030643 |
Web of Science KeyUT | 000529337400120 |
関連URL | isVersionOf https://doi.org/10.3390/cells9030643 |
JaLCDOI | 10.18926/AMO/58274 |
---|---|
フルテキストURL | 74_2_151.pdf |
著者 | Yamamoto, Norio| Dan’ura, Tomoyuki| Noda, Tomoyuki| Ozaki, Toshifumi| |
抄録 | This is the second report of an atypical peri-implant femoral fracture occurring at the distal screw after intramedullary nail fixation of a pertrochanteric fracture. A 94-year-old Japanese female with a 5-year history of alendronate intake presented with prodromal pain in her right thigh after intramedullary nail fixation. Plain radiographs showed an incomplete noncomminuted transverse fracture at the distal screw, suggesting an atypical peri-implant femoral fracture. The pathogenesis of an atypical peri-implant femoral fracture could be a combined systemic bone metabolism disorder and repetitive overloading at the screw, similar to the pathogenesis of an atypical periprosthetic femoral fracture around stem implantation. |
キーワード | atypical femoral fracture insufficiency fracture bisphosphonate atypical peri-implant femoral fracture, atypical periprosthetic femoral fracture |
Amo Type | Case Report |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-04 |
巻 | 74巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 151 |
終了ページ | 157 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32341590 |
Web of Science KeyUT | 000528278500009 |
NAID | 120006839453 |
JaLCDOI | 10.18926/AMO/58271 |
---|---|
フルテキストURL | 74_2_129.pdf |
著者 | Fukuma, Shogo| Shinya, Takayoshi| Soh, Junichi| Fukuhara, Ryuichiro| Ogawa, Nanako| Higaki, Fumiyo| Tanaka, Takehiro| Ichihara, Eiki| Hiraki, Takao| Toyooka, Shinichi| Kanazawa, Susumu| |
抄録 | The aim of this study was to explore enhancement patterns of different types of primary lung cancers on 2-phase dynamic computed tomography (CT). This study included 217 primary lung cancer patients (141 adenocarcinomas [ADs], 48 squamous cell carcinomas [SCCs], 20 small cell lung carcinomas [SCLCs], and 8 others) who were examined using a 2-phase dynamic scan. Regions of interest were identified and mean enhancement values were calculated. After excluding the 20 SCLCs because these lesions had different clinical stages from the other cancer types, the mean attenuation values and subtractions between phases were compared between types of non-small cell lung carcinomas (NSCLCs) using the Kruskal–Wallis test. Late phase attenuation and attenuation of the late minus unenhanced phase (LMU) of SCCs were significantly higher than those of ADs (p<0.05). To differentiate SCC and AD in the late phase, a threshold of 80.21 Hounsfield units (HU) gave 52.9% accuracy. In LMU, a threshold of 52.16 HU gave 59.3% accuracy. Dynamic lung CT has the potential to aid in differentiating among NSCLC types. |
キーワード | differentiation dynamic computed tomography primary lung cancer enhancement pattern |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-04 |
巻 | 74巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 129 |
終了ページ | 135 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32341587 |
Web of Science KeyUT | 000528278500006 |
NAID | 120006839450 |
JaLCDOI | 10.18926/AMO/58267 |
---|---|
フルテキストURL | 74_2_103.pdf |
著者 | Kawada, Yasumasa| Kubo, Toru| Baba, Yuichi| Hirota, Takayoshi| Tanioka, Katsutoshi| Yamasaki, Naohito| Kitaoka, Hiroaki| |
抄録 | This study examined whether switching from amlodipine and atorvastatin treatment using two pills to an equal dose of single-pill therapy is useful in Japanese outpatients. We retrospectively reviewed data obtained from 94 outpatients for whom treatment with two pills, namely amlodipine and atorvastatin, was switched to an equal dose of single-pill therapy in 11 hospitals. The criterion for enrollment in this study was that patients had switched their medication without changing other anti-hypertensive or anti-cholesterol drugs. Neither systolic nor diastolic blood pressure changed significantly after switching to an equal dose of single-pill therapy, whereas low-density lipoprotein (LDL) cholesterol levels significantly decreased after the medication was switched from 94±24 mg/dl to 89±17 mg/dl (p=0.015). A switch from medication with two separate pills of amlodipine and atorvastatin to an equal dose of single-pill therapy resulted in an overall decrease in LDL cholesterol. The results indicated that the switch to single-pill therapy might be a useful treatment. |
キーワード | hypertension dyslipidemia single-pill therapy |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-04 |
巻 | 74巻 |
号 | 2号 |
出版者 | Okayama University Medical School |
開始ページ | 103 |
終了ページ | 108 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32341583 |
Web of Science KeyUT | 000528278500002 |
NAID | 120006839446 |
フルテキストURL | fulltext.pdf |
---|---|
著者 | Kato, Koji| Shinoda, Toshiyuki| Nagao, Ryo| Akimoto, Seiji| Suzuki, Takehiro| Dohmae, Naoshi| Chen, Min| Allakhverdiev, Suleyman I.| Shen, Jian-Ren| Akita, Fusamichi| Miyazaki, Naoyuki| Tomo, Tatsuya| |
発行日 | 2020-01-13 |
出版物タイトル | Nature Communications |
巻 | 11巻 |
号 | 1号 |
出版者 | Nature Research |
開始ページ | 238 |
ISSN | 2041-1723 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
著作権者 | © The Author(s) 2020 |
論文のバージョン | publisher |
PubMed ID | 31932639 |
DOI | 10.1038/s41467-019-13898-5 |
Web of Science KeyUT | 000511916800016 |
関連URL | isVersionOf https://doi.org/10.1038/s41467-019-13898-5 |
JaLCDOI | 10.18926/AMO/57959 |
---|---|
フルテキストURL | 74_1_89.pdf |
著者 | Kada, Akiko| Fukano, Reiji| Mori, Tetsuya| Kamei, Michi| Tanaka, Fumiko| Ueyama, Junichi| Sekimizu, Masahiro| Osumi, Tomoo| Mori, Takeshi| Koga, Yuhki| Ohki, Kentaro| Fujita, Naoto| Mitsui, Tetsuo| Saito, Akiko M.| Hashimoto, Hiroya| Kobayashi, Ryoji| |
抄録 | No standard treatment for relapsed or refractory anaplastic large-cell lymphoma (ALCL) has been established. This study is a multicenter, open-label trial to examine the effectiveness and safety of transplantation with reduced-intensity conditioning (RIC) for patients under 20 years old with relapsed or refractory ALCL. We defined RIC as the administration of fludarabine (30 mg/m2/day) for five days plus melphalan (70 mg/m2/day) for two days and total body irradiation at 4 Gy, followed by allogeneic hematopoietic stem cell transplantation. |
キーワード | anaplastic large-cell lymphoma relapsed/refractory fludarabine melphalan total body irradiation |
Amo Type | Clinical Study Protocol |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-02 |
巻 | 74巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 89 |
終了ページ | 94 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32099255 |
Web of Science KeyUT | 000516606200014 |
NAID | 120006795626 |
JaLCDOI | 10.18926/AMO/57950 |
---|---|
フルテキストURL | 74_1_33.pdf |
著者 | Honda, Hiroyuki| Hanayama, Yoshihisa| Obika, Mikako| Hasegawa, Kou| Hamahara, Jun| Kishida, Masayuki| Hagiya, Hideharu| Ogawa, Hiroko| Kataoka, Hitomi| Otsuka, Fumio| |
抄録 | A relationship between diabetes and depression is apparent. To clarify the clinical relevance of diabetic patients’ gastroesophageal symptoms to their psychological status, we retrospectively analyzed the data from a Selfrating Depression Scale (SDS) and a Frequency Scale for Symptoms of Gastroesophageal reflux disease (FSSG) among 143 type 2 diabetic patients who visited a general medicine department. Among the 45 Japanese patients enrolled, the group with relatively high SDS scores (≥ 36) showed higher (FSSG) dysmotility symptom scores versus the low-SDS (< 36) group, although the 2 groups’ characteristics and laboratory data were not significantly different. Positive correlations of postprandial plasma glucose (PPG) levels with FSSG scores (R=0.321, p<0.05), particularly with reflux scores (R=0.455, p<0.01) were revealed. PPG and HbA1c levels were not correlated with SDS scores. The patients’ SDS scores were significantly correlated with their FSSG scores (R=0.41, p<0.01), suggesting that depressive status is linked to GERD-related manifestations. Considering that the patients’ PPG levels were correlated with GERD-related symptoms, diabetic patients’ blood glucose levels are associated with depressive status. Collectively, key symptoms related to GERD and glucose level values would be helpful |
キーワード | blood glucose type 2 diabetes mellitus gastroesophageal reflux depressive status postprandial plasma glucose |
Amo Type | Original Article |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-02 |
巻 | 74巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 33 |
終了ページ | 40 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32099246 |
Web of Science KeyUT | 000516606200005 |
NAID | 120006795617 |
JaLCDOI | 10.18926/AMO/57946 |
---|---|
フルテキストURL | 74_1_1.pdf |
著者 | Chen, Yuehua| Ohara, Toshiaki| Xing, Boyi| Qi, Jiping| Noma, Kazuhiro| Matsukawa, Akihiro| |
抄録 | Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings. |
キーワード | cancer stem cell stemness iron chelation chemotherapy |
Amo Type | Review |
出版物タイトル | Acta Medica Okayama |
発行日 | 2020-02 |
巻 | 74巻 |
号 | 1号 |
出版者 | Okayama University Medical School |
開始ページ | 1 |
終了ページ | 6 |
ISSN | 0386-300X |
NCID | AA00508441 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
著作権者 | CopyrightⒸ 2020 by Okayama University Medical School |
論文のバージョン | publisher |
査読 | 有り |
PubMed ID | 32099242 |
Web of Science KeyUT | 000516606200001 |
NAID | 120006795613 |
フルテキストURL | ST49_8_686.pdf |
---|---|
著者 | Sugimoto, Seiichiro| Yamamoto, Haruchika| Kurosaki, Takeshi| Otani, Shinji| Okazaki, Mikio| Yamane, Masaomi| Toyooka, Shinichi| Oto, Takahiro| |
キーワード | Bronchiolitis obliterans syndrome Chronic lung allograft dysfunction Living-donor Lung transplantation Rejection Restrictive allograft syndrome |
発行日 | 2019-02-21 |
出版物タイトル | Surgery Today |
巻 | 49巻 |
号 | 8号 |
出版者 | Springer |
開始ページ | 686 |
終了ページ | 693 |
ISSN | 0941-1291 |
NCID | AA10824685 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
PubMed ID | 30790054 |
DOI | 10.1007/s00595-019-01782-0 |
Web of Science KeyUT | 000476536300007 |
関連URL | isVersionOf https://doi.org/10.1007/s00595-019-01782-0 |
フルテキストURL | NCN7_3_146.pdf Fig.pdf |
---|---|
著者 | Matsumoto, Namiko| Sato, Kota| Takahashi, Yoshiaki| Kawahara, Yuko| Yunoki, Taijun| Shang, Jingwei| Takemoto, Mami| Hishikawa, Nozomi| Ohta, Yasuyuki| Yamashita, Toru| Sakamoto, Maiko| Kondou, Eisei| Shibata, Rei| Yoshino, Tadashi| Ozaki, Toshifumi| Abe, Koji| |
キーワード | neurolymphomatosis neuro-oncology peripheral neuropathy peripheral nerve rheumatoid arthritis T-cell lymphoma |
備考 | This fulltext will be available in Feb 2020| |
発行日 | 2019-02-19 |
出版物タイトル | Neurology and Clinical Neuroscience |
巻 | 7巻 |
号 | 3号 |
出版者 | Wiley |
開始ページ | 146 |
終了ページ | 149 |
ISSN | 2049-4173 |
資料タイプ | 学術雑誌論文 |
言語 | 英語 |
OAI-PMH Set | 岡山大学 |
論文のバージョン | author |
DOI | 10.1111/ncn3.12280 |
Web of Science KeyUT | 000466785700011 |
関連URL | isVersionOf https://doi.org/10.1111/ncn3.12280 |